Manufacturer record
Accent Pharmaceuticals & Diagnostics: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Accent Pharmaceuticals & Diagnostics (Himachal Pradesh) were declared Not of Standard Quality between May 2023 and November 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Accent Pharmaceuticals & Diagnostics in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Tablets IP (Paracent 650 Tablets) | 24GT079Mfg 2024-03 · Exp 2027-02 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Nov 2024 |
| Paracetamol, Phenylephrine Hydrochloride & Cetirizine Hydrochloride Tablets (PHS NCOLD PLUS) | 22GT048Mfg 2022-03 · Exp 2025-02 | DescriptionDescription | RDTL GuwahatiState lab | Sep 2023 |
| Misoprostol Tablets I.P. 200 mcg | 22HT303Mfg 2022-11 · Exp 2024-10 | AssayAssay | CDL KolkataCDSCO lab | May 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.